Phillipe Moreau

75PUBLICATIONS
209CO-AUTHORS
Predictive and prognostic markersMedical mycologyGene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Jul 03, 2026
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Feb 25, 2026
Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM).

Alexis Talbot, Bernard Delcour, Laurent Gillot

|Oct 24, 2025
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Philippe Moreau, Cyrille Hulin, Alexis Talbot

|Sep 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges.

Cyrille Touzeau, Philippe Moreau

|Aug 07, 2025
Simultaneous whole-body multi-parametric 2-[18F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact.

Bastien Jamet, Cyrille Touzeau, Hatem Necib

Pageof 13

Frequent Collaborators

18 joint publications

Cyrille Touzeau

17 joint publications

Meletios-Athanasios Dimopoulos

13 joint publications

Xavier Leleu

13 joint publications

Aurore Perrot